IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Operating income 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual operating income history from SEC filings — each fiscal year as reported.
-$403.4MFY2025 · since FY2016: -$53.6M → -$403.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$403.4M | -2.0% |
| FY2024 | -$395.3M | +14.2% |
| FY2023 | -$460.6M | -15.5% |
| FY2022 | -$398.9M | -16.4% |
| FY2021 | -$342.7M | -30.8% |
| FY2020 | -$261.9M | -26.6% |
| FY2019 | -$206.9M | -61.3% |
| FY2018 | -$128.3M | -38.1% |
| FY2017 | -$92.9M | -73.2% |
| FY2016 | -$53.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice